Caffeine improves bladder function in streptozotocin-induced diabetic rats

Neurourol Urodyn. 2019 Jan;38(1):81-86. doi: 10.1002/nau.23799. Epub 2018 Nov 9.

Abstract

Aims: To examine the protective effects of caffeine in rats with diabetes mellitus (DM) by using urodynamics.

Methods: Female Sprague-Dawley rats (n = 24) were divided into four groups: control group, DM group, DM + caffeine (5 mg/kg/day), and DM + caffeine (10 mg/kg/day). DM was induced by streptozotocin (STZ). Cystometric studies were conducted on all rats. After 8 weeks of treatment with caffeine, the urodynamic parameters, including bladder capacity, residual urine volume, voiding time, and peak voiding pressure, were measured.

Results: DM rats had a higher bladder capacity and post-void residual urine volume (PVR), an increased voiding time and peak voiding pressure, and a markedly lower voiding efficiency than the control group rats. After treatment with caffeine, bladder capacity, post-void residual urine volume, and peak voiding pressure were significant lower than those in the DM group, but voiding efficiency was markedly higher.

Conclusion: The results suggested that caffeine (5 or 10 mg/kg/day) may improve the bladder function at 8 weeks after STZ induction. Thus, this may represent a potential strategy to increase voiding efficiency in diabetes.

Keywords: bladder; caffeine; diabetic; urodynamics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Caffeine / therapeutic use*
  • Central Nervous System Stimulants / therapeutic use*
  • Diabetes Mellitus, Experimental / complications*
  • Dose-Response Relationship, Drug
  • Female
  • Rats
  • Rats, Sprague-Dawley
  • Urinary Bladder / physiopathology*
  • Urinary Retention / drug therapy
  • Urinary Retention / etiology
  • Urinary Retention / physiopathology
  • Urination / drug effects
  • Urodynamics

Substances

  • Central Nervous System Stimulants
  • Caffeine